Article

Anti-V2 Antibody Deficiency in Individuals Infected With HIV-1

2018-06-02

Abstract excerpt

<h4>ABSTRACT</h4> The positive correlation of high levels of plasma anti-V2 antibodies (Abs) with protective immunity in the Phase III anti-HIV RV144 vaccine trial generated interest in the induction of these Abs for HIV vaccine development. We analyzed plasma samples from 79 chronically infected Cameroonian individuals for Ab reactivity against three V1V2 fusion proteins and five cyclic V2 peptides and found tha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd3b1a15-1b68-54d0-9eb1-1f8a1bef71e7
DOI: 10.1101/336339

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Anti-V2 Antibody Deficiency in Individuals Infected With HIV-1DOI 10.1101/336339Read

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and ImmunotypesSemantic proximity Read

Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization SensitivitySemantic proximity Read

Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.Semantic proximity Read

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing AntibodiesSemantic proximity Read

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.Semantic proximity Read

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic ActivitySemantic proximity Read

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144Semantic proximity Read

Infection by Discordant Strains of HIV-1 Markedly Enhances the Neutralizing Antibody Response against Heterologous VirusSemantic proximity Read

Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized miceSemantic proximity Read

Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.Semantic proximity Read

Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.Semantic proximity Read

Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodiesSemantic proximity Read